220 related articles for article (PubMed ID: 13199654)
1. The provisional international standard antityphoid serum.
FELIX A
Bull World Health Organ; 1954; 10(6):911-7. PubMed ID: 13199654
[TBL] [Abstract][Full Text] [Related]
2. Proposed standard agglutinating sera for typhoid and paratyphoid A and B fevers.
FELIX A; BENSTED HJ
Bull World Health Organ; 1954; 10(6):919-26. PubMed ID: 13199655
[TBL] [Abstract][Full Text] [Related]
3. [EVALUATION OF VACCINES AND OF THE EFFECTIVENESS OF VACCINATIONS AGAINST TYPHOID FEVER. XII. AGGLUTINATING ANTIBODIES IN RABBIT SERA AFTER THE IMMUNIZATION WITH ANTITYPHOID VACCINES].
MEISLOWA P; RABCZYNSKA F; KUDELSKI Z
Przegl Epidemiol; 1963; 17():81-7. PubMed ID: 14054902
[No Abstract] [Full Text] [Related]
4. [The problem of control of anti-typhoid vaccines. V. The immunogenic value of antityphoid vaccines in relation to the antigenic structure of the strains used in their preparation].
Gabbrielli G; Buzzanca E
Boll Soc Ital Biol Sper; 1968 Apr; 44(8):725-8. PubMed ID: 5698500
[No Abstract] [Full Text] [Related]
5. Studies on infection and immunity in experimental typhoid fever. III. Effect of prophylactic immunization.
GAINES S; LANDY M; EDSALL G; MANDEL AD; TRAPANI RJ; BENENSON AS
J Exp Med; 1961 Sep; 114(3):327-42. PubMed ID: 13702952
[TBL] [Abstract][Full Text] [Related]
6. Studies of immunity in typhoid fever. Protection induced by killed oral antigens or by primary infection.
Dupont HL; Hornick RB; Snyder MJ; Dawkins AT; Heiner GG; Woodward TE
Bull World Health Organ; 1971; 44(5):667-72. PubMed ID: 5316750
[TBL] [Abstract][Full Text] [Related]
7. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
Bhutta ZA; Capeding MR; Bavdekar A; Marchetti E; Ariff S; Soofi SB; Anemona A; Habib MA; Alberto E; Juvekar S; Khan RM; Marhaba R; Ali N; Malubay N; Kawade A; Saul A; Martin LB; Podda A
Lancet Infect Dis; 2014 Feb; 14(2):119-29. PubMed ID: 24290843
[TBL] [Abstract][Full Text] [Related]
9. [EVALUATION OF VACCINES AND THE EFFECTIVNESS OF ANTI-TYPHOID VACCINATION. XX. THE LEVEL OF AGGLUTININS O, H. VI IN THE BLOOD SERUM 2 YEARS AFTER VACCINATION WITH VACCINES K, N, P, S, T AND 2 WEEKS AFTER VACCINATION WITH VACCINE P].
NARUSZEWICZ-LESIUK D; SZELAG J
Przegl Epidemiol; 1964; 18():355-7. PubMed ID: 14298606
[No Abstract] [Full Text] [Related]
10. Antityphoid and antitetanic intradermal vaccination of chronic neuropsychic patients in a typhoid fever outbreak.
Dimache G; Croitoru M; Ionescu M; Săvulescu M; Durbacă S; Dimache A
Roum Arch Microbiol Immunol; 1991; 50(1):37-43. PubMed ID: 1802050
[TBL] [Abstract][Full Text] [Related]
11. [EVALUATION OF VACCINES AND OF THE EFFECTIVENESS OF VACCINATIONS AGAINST TYPHOID FEVER. VIII. SEROLOGICAL REACTIONS IN SUBJECTS VACCINATED WITH VARIOUS ANTITYPHOID VACCINES].
KOPACKA B; SLUBICKA A
Przegl Epidemiol; 1963; 17():55-62. PubMed ID: 14053745
[No Abstract] [Full Text] [Related]
12. [EVALUATION OF VACCINES AND THE EFFECTIVENESS OF ANTI-TYPHOID VACCINATION. XXI. THE LEVEL OF AGGLUTININS O, H, VI AND THE HEMAGGLUTIN VI IN SERA OF RABBITS VACCINATED WITH ANTI-TYPHOID VACCINES K, N, P, S, T].
NARUSZEWICZ-LESIUK D
Przegl Epidemiol; 1964; 18():359-62. PubMed ID: 14295117
[No Abstract] [Full Text] [Related]
13. A SUGGESTION FOR A NEW ANTITYPHOID VACCINE.
ANDERSON ES; GUNNELL A
Lancet; 1964 Dec; 2(7371):1196-200. PubMed ID: 14215557
[No Abstract] [Full Text] [Related]
14. Immunity reactions in man and animals following inoculation with typhoid vaccines, with special reference to the bactericidal activity of the serum.
KAROLCEK J; ODLER I; DRASKOVICOVA M
J Hyg Epidemiol Microbiol Immunol; 1961; 5():210-23. PubMed ID: 13751551
[No Abstract] [Full Text] [Related]
15. [NOTES ON PASSIVE PROTECTION OF MICE WITH HUMAN VI SERUMS].
GARIBOLDI M; FARA GM
Boll Ist Sieroter Milan; 1963; 42():624-9. PubMed ID: 14120784
[No Abstract] [Full Text] [Related]
16. [The problem of control of antityphoid vaccines. IV. Experimental study of the immunogenic value of antityphoid vaccines tested by various methods].
GABBRIELLI G; MORGANTETTI F
Riv Ist Sieroter Ital; 1960; 35():498-504. PubMed ID: 13702758
[No Abstract] [Full Text] [Related]
17. Antibody responses of man to three types of antityphoid immunizing agents: heat-phenol fluid vaccine, acetone-dehydrated vaccine, and isolated Vi and O antigens.
LANDY M; GAINES S; SEAL JR; WHITSIDE JE
Am J Public Health Nations Health; 1954 Dec; 44(12):1572-9. PubMed ID: 13207484
[No Abstract] [Full Text] [Related]
18. [Mazzetti's method of evaluation of protective efficacy of vaccines; application of control in antityphoid-paratyphoid vaccination].
FRENI S
G Med Mil; 1952; 102(3):209-23. PubMed ID: 12989586
[No Abstract] [Full Text] [Related]
19. [Oral antityphoid vaccination].
Pontecorvo M
Riv Ist Sieroter Ital; 1967; 42(4):198-204. PubMed ID: 5596591
[No Abstract] [Full Text] [Related]
20. Experimental study on intradermal antitetanus antityphoid immunization.
Dimache G; Stoean C; Durbacă S; Laşcu N; Croitoru M; Dimache A
Roum Arch Microbiol Immunol; 1992; 51(1-2):53-65. PubMed ID: 1457823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
